Friday's Preview: Can Dr. Reddy's Laboratories continue its recent gains?

Dr. Reddy's Laboratories (DRL) faces a crucial test today as it seeks to build on its recent upward momentum. The stock has shown resilience, rising for three consecutive sessions as of February 6, with a 1.14% gain to Rs 1241.5. However, DRL has experienced volatility, dropping 7.04% on January 24 and declining 9.83% over the past month. Despite these challenges, the company reported stable Q3 FY24-25 performance, maintaining a low debt-to-equity ratio and demonstrating healthy long-term growth in net sales and operating profit. Investors will be watching closely to see if DRL can overcome recent market headwinds and continue its positive trajectory.
Source: Economic Times, Business Standard, MarketsMojo